Literature DB >> 8428878

Clozapine for schizophrenia.

B Blanz, M H Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8428878     DOI： 10.1097/00004583-199301000-00039

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  7 in total

Review 1.  Effective treatment for mental disorders in children and adolescents.

Authors:  B J Burns; K Hoagwood; P J Mrazek
Journal:  Clin Child Fam Psychol Rev       Date:  1999-12

Review 2.  Atypical neuroleptics in child and adolescent psychiatry.

Authors:  H Remschmidt; K Hennighausen; H W Clement; P Heiser; E Schulz
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

3.  Blood biogenic amines during clozapine treatment of early-onset schizophrenia.

Authors:  E Schulz; C Fleischhaker; H W Clement; H Remschmidt
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 4.  Tolerability profile of atypical antipsychotics in children and adolescents.

Authors:  K A Stigler; M N Potenza; C J McDougle
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 5.  Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.

Authors:  Paz Toren; Sharon Ratner; Nathaniel Laor; Abraham Weizman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 6.  Management of schizophrenia in children and adolescents. The role of clozapine.

Authors:  H Remschmidt; C Fleischhaker; K Hennighausen; E Schulz
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.930

Review 7.  Antipsychotics in children and adolescents with schizophrenia: a systematic review and meta-analysis.

Authors:  Siddharth Sarkar; Sandeep Grover
Journal:  Indian J Pharmacol       Date:  2013 Sep-Oct       Impact factor: 1.200
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.